Choroidal Hemangioma Masquerading as Central Serous Chorioretinopathy
نویسنده
چکیده
C horoidal hemangioma is a relatively rare, benign vascular hamartoma. The circumscribed type is classically unilateral and is believed to be congenital in origin.1,2 Circumscribed choroidal hemangioma typically appears as a slightly oval or round, red-orange mass in the macular or perimacular region of the choroid, often with clinically indistinct borders.1-3 Although choroidal hemangioma is benign, this tumor can manifest progressive retinal detachment with poor visual acuity; rarely does this condition necessitate enucleation. In a review of 200 cases of choroidal hemangioma by Shields et al,1 54% of patients were found to have a visual acuity of 20/200 or worse at initial presentation, and enucleation was necessary in 3 cases. Thus, timely recognition and appropriate management of this tumor is important for visual outcome. Choroidal hemangioma can be misdiagnosed as amelanotic melanoma, choroidal metastasis, central serous chorioretinopathy (CSC), and, in some instances, it remains clinically undetected despite visual loss.1 Herein, we report a case of choroidal hemangioma that was clinically undetected despite visual loss for more than 1 year and later treated as CSC until an underlying subtle hemangioma was detected.
منابع مشابه
Photodynamic Therapy for Choroidal Neovascularization
Photodynamic therapy is considered investigational when used in combination with one or more of the anti-vascular endothelial growth factor therapies (anti-VEGF), i.e., pegatanib (Macugen), ranibizumab (Lucentis), bevacizumab (Avastin), aflibercept (EyleaTM) as a treatment of CNV associated with agerelated macular degeneration, chronic central serous chorioretinopathy, choroidal hemangioma, pat...
متن کاملCentral serous chorioretinopathy treated with topical dorzolamide: A case series study
Abstract The aim of this study was to investigate the improvements of central serous chorioretinopathy (CSC) treated with topical dorzolamide. These observational case studies included nine eyes of the nine patients with CSC, treated by a physician with topical dorzolamide consecutively over a one-month period. The central macular thickness and best-corrected visual acuity (BCVA) were measured...
متن کاملNeovascular Phenotypes: Polypoidal Choroidal Vasculopathy Authors:
Polypoidal choroidal vasculopathy has also been described in different pathological conditions including central serous chorioretinopathy(5), circumscribed choroidal hemangioma(6); melanocytoma of the optic nerve(7); pathological myopia and staphyloma(8); or choroidal osteoma(9). PCV seems to behave more like a neovasculopathy occurring in a variety of different diagnoses than a distinct abnorm...
متن کاملPhotodynamic Therapy and Central Serous Chorioretinopathy
Central serous chorioretinopathy is a common acquired maculopathy. Multiple studies showed that photodynamic therapy is useful treatment for acute and chronic central serous chorioretinopathy. The exact mechanism of photodynamic therapy in treating central serous chorioretinopathy is not clear, but it is thought to be caused by short-term choriocapillaris hypoperfusion and long-term choroidal v...
متن کامل[Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in central serous chorioretinopathy: case report].
We report the use of photodynamic therapy with verteporfin for subfoveal choroidal neovacularization in central serous chorioretinopathy. Visual acuity improved (0.5 to 1.0) 30 days after the first session. After 141 days, the choroidal neovascularization reactivated and the patient was retreated. Again, visual acuity improved (0.5 to 1.0) 30 days afterwards. It remains stable after 20 months. ...
متن کامل